Urgent reversal of antithrombotic therapy: module 1 Overview

Released 21 October 2021     Expires: 21 October 2023      Programme: Anticoagulation reversal 1.5 CPD/CME credits

Sponsorship Statement: This module has been sponsored by Alexion Pharmaceuticals UK Ltd.

This module is designed to give healthcare professionals a clear understanding of when and how to reverse antithrombotic therapy.

Module published: 21st October 2021

Learning objectives

  • Understanding when to reverse antithrombotic treatment and its risks
  • The treatment options and evidence for reversing antithrombotic therapy
  • The practical management of major bleeding
  • Actions needed in a number of clinical situations.


Dr Richard J Buka, ST6 Haematology Registrar, University Hospitals North Midlands NHS Trust; Honorary Clinical Research Fellow, Institute of Cardiovascular Sciences, University of Birmingham
Dr David J Sutton, Consultant Haematologist, University Hospitals North Midlands NHS Trust, Staffordshire


BJC Learning has assigned 1.5 hours of CPD/CME credits to this module

To make the “Take test” button available – please click the “Module content” button first.

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

7 thoughts on “Urgent reversal of antithrombotic therapy: module 1 Overview”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.